
    
      The glucagon response to mild (3.0 mmol/l) hypoglycemia with and without DPP-4 inhibition by
      sitagliptin will be evaluated in elderly subjects with metformin treated type 2 diabetes to
      explore whether DPP-4 inhibition affects glucagon counter-regulation.
    
  